Scan QR
Lumakras (sotorasib) is an advanced inhibitor of the RAS GTPase family, offering a breakthrough treatment for KRAS G12C-mutated cancers, including locally advanced or metastatic NSCLC and metastatic colorectal cancer. Patients often inquire about Lumakras price in India because this therapy is not yet marketed locally. The dosage is 960 mg once daily, either as a single agent in lung cancer or in combination with panitumumab for colorectal cancer. Tablets should be swallowed whole, without crushing or chewing. Since Lumakras is not approved in the Indian market, patients who need it can still gain access through the Named Patient Program (NPP) under medical supervision. This ensures regulated, safe, and timely ...
Scan QR
Lumakras (sotorasib) is an advanced inhibitor of the RAS GTPase family, offering a breakthrough treatment for KRAS G12C-mutated cancers, including locally advanced or metastatic NSCLC and metastatic colorectal cancer. Patients often inquire about Lumakras price in India because this therapy is not yet marketed locally. The dosage is 960 mg once daily, either as a single agent in lung cancer or in combination with panitumumab for colorectal cancer. Tablets should be swallowed whole, without crushing or chewing. Since Lumakras is not approved in the Indian market, patients who need it can still gain access through the Named Patient Program (NPP) under medical supervision. This ensures regulated, safe, and timely access to authentic treatment.
Loading
